Examination Of The Protective Efficiency Of The Fruit Extract And Fruit Vinegar Of The Hawthorn (Crataegus Tanacetifolia) Plant Against Hyperlipidemia And Possible Endothelial Damage In An Experimentally Induced Model Of Hyperlipidemia In Rats
Abstract
Atherosclerosis is one of the leading causes of death in humans worldwide. Hyperlipidaemia is a significant risk factor for atherosclerosis and is characterised by accelerated atherosclerosis. However, factors such as homocysteine, adhesion molecules, and low HDL-C levels have been reported to play a role in the development of atherosclerosis and hyperlipidaemia. This study aimed to investigate the effects of hawthorn (Crataegus tanacetifolia) fruit extract and fruit vinegar on total cholesterol (TC), triglycerides (TG), Nitrit (NOx), HDL-C, LDL-C, homocysteine, P-selectin, and VCAM-1 levels, which are among the factors causing hyperlipidaemia and atherosclerosis. In the study, hawthorn extract (HE) and hawthorn vinegar (HV) were administered by gavage to rats with experimentally induced hyperlipidaemia (HL). Rats were divided into seven groups. The control group was fed a normal diet. Blood samples taken at the beginning of the study and the end of the fourth and eighth weeks were separated, and the levels of TC, TG, NOx, HDL-C, LDL-C, homocysteine, P-selectin, and VCAM-1 were measured. Our results showed that adding HE or HV to the diet reduced homocysteine, P-selectin, TC, LDL-C, NOx and TG levels and increased HDL-C levels. In conclusion, the results of this study, in which we hypothesised that hawthorn fruit extract and fruit vinegar may reduce the risk of atherosclerosis, which increases in correlation with hyperlipidaemia, hypercholesterolaemia, hyperhomocysteinemia and increased levels of adhesion molecules caused by a high-fat diet, showed that hawthorn fruit extract had a strong antiatherogenic effect
Keywords
Hawthorn, Hawthorn vinegar, Crataegus tanacetifolia, Hyperlipidaemia, Atherosclerosis
Supporting Institution
Inonu Univertsity
Project Number
2011/148
Ethical Statement
I declare that all processes of the study are in accordance with research and publication ethics, and that I comply with ethical rules and scientific citation principles.
Thanks
We would like to thank Inönü University Scientific Research Coordination Unit for providing financial support for this study.
References
- [1] Tanrıverdi B, Tetik ŞS. Aterosklerozun patofizyolojisi ve risk faktörleri-A review. Marmara Pharmaceutical Journal, 2017; 21: 1-9. DOI: 10.12991/marupj.259875.
- [2] Rağbetli C. Hiperlipidemi. Van Tıp Dergisi, 2009;16 (1): 43-47.
- [3] Büyükbingöl Z. ( 2025, 19 Eylül ). Ateroskleroz ve Diğer Lipit Metabolizması Bozuklukları Ankara Üniversitesi Açık Ders Malzemeleri. reached https://acikders.ankara.edu.tr/mod/resource/view.php?id=60897
- [4] Davignon J, Ganz P. Role of endothelial dysfunction in atherosclerosis. Circulation. 2004;109:III27-32.
- [5] Delanty N, Vaughan CJ. Vascular effects of statin in stroke. Stroke, 1997;28:1-15.
- [6] Eryavuz OD, Aydoğan C, Aygül N, Sivrikaya A. et al. Periferik arter hastalarında yükselmiş serum homositrulin düzeyleri. Turk Hij Den Biyol Derg. 2022;79(1):103-114.
- [7] Hansson GK., Nilsson, J. Pathogenesis of Atherosclerosis. In: Crawford, M.H., Di Marco, J.P., Paulus, W.J., eds. Cardiology. 3rd Ed. 2010, Philadelphia. Mosby Elsevier, 1-12.
- [8] Kumar, V., Cotran, RS., Robbins, SL. Atherosklerosis. Basic Pathology. 6.baskı. 1997, Elsevier/ Nobel Tıp Kitabevleri, 282-288. [9] Ross R. Atherosclerosis- an inflammatory disease. N Engl J Med. 1999; 340:115-126.
- [10] Barış N, Sipahi İ, Tuzcu EM. Koroner Aterosklerozun Görüntülenmesinde İntravasküler Ultrasonografi Beklentilerimizin Ne Kadarını Karşılıyor. Fırat Tıp Dergisi. 2006;11(1): 1-5.
- [11] Fuster V, Alexander RW, O’Rourke R. Aterogenez ve Belirleyicileri. In: The Heart 10. Baskı. 2002, New York : McGraw-Hill. 1065-1075.